Abstract
The past decade has seen exciting progress in the management of lupus nephritis, a manifestation of systemic lupus erythematosus that accounts for its major morbidity and mortality. The American College of Rheumatology has issued new guidelines for screening and treatment of lupus nephritis, based on expert recommendations.
MeSH terms
-
Cyclophosphamide / administration & dosage*
-
Glucocorticoids / administration & dosage
-
Humans
-
Immunosuppressive Agents / administration & dosage*
-
Lupus Nephritis / drug therapy*
-
Maintenance Chemotherapy
-
Mycophenolic Acid / administration & dosage
-
Mycophenolic Acid / analogs & derivatives*
-
Practice Guidelines as Topic
-
Remission Induction
Substances
-
Glucocorticoids
-
Immunosuppressive Agents
-
Cyclophosphamide
-
Mycophenolic Acid